Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
95.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
100.0 |
Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
100.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
112.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
109.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
104.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
116.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
131.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
108.0 |
Antitumor endpoint evaluated on day 30; 09/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
127.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |